CARREKER CORPORATION – Trademark Portfolio
Entity Type: 03
CARREKER CORPORATION holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 12 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include NEXGEN, FRAUDLINK, MATCHPOINT, RESERVELINK, and EXCEPTIONS EXPRESS. The owner is based in DALLAS, TX.
4055 VALLEY VIEW LANE, #1000
DALLAS, TX 75244
Showing of trademarks Trademarks
Trademark Classifications
CARREKER CORPORATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does CARREKER CORPORATION have?
CARREKER CORPORATION has 16 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 abandoned, 9 cancelled.
What trademark classes does CARREKER CORPORATION file in?
CARREKER CORPORATION files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are CARREKER CORPORATION's most well-known trademarks?
CARREKER CORPORATION's registered trademark portfolio includes well-known marks such as NEXGEN, FRAUDLINK, MATCHPOINT, RESERVELINK, and EXCEPTIONS EXPRESS. These are among 5 currently registered trademarks in the portfolio.
What is CARREKER CORPORATION's trademark registration success rate?
CARREKER CORPORATION has a 31% trademark registration rate, with 5 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.